Tag: iADC platform

Boehringer Ingelheim to acquire NBE-Therapeutics for €1.1bn

pharmanewsdaily- December 11, 2020

German pharma company Boehringer Ingelheim has signed a deal worth €1.18 billion to acquire NBE-Therapeutics, a clinical-stage Switzerland-based biotech company, focused on developing antibody-drug conjugates ... Read More